Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2003
08/07/2003US20030149256 Transferrin polynucleotides, polypeptides, and antibodies
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149244 Adjusting affinity of Fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149241 Nucleotide sequences coding osteogenic protein for induction/differentiation and/or treatment of bone, cartilage and other connective tissue defects; wound healing agents
08/07/2003US20030149239 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030149238 Novel compounds
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148943 Novel tachykinin-like polypeptides and use thereof
08/07/2003US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders
08/07/2003US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells
08/07/2003US20030148496 Cell-free system for translation and formation of HTLV lymphadenopathy associated viral coat proteins; viricides; drug screening
08/07/2003US20030148495 Useful mutations of bacterial alkaline protease
08/07/2003US20030148493 Sialidase and recombinant cell lines
08/07/2003US20030148491 Comprises receptor-like protein tyrosine phosphatase polypeptides (DEP-1) for use as antiinflammatory/anticarcinogenic agents
08/07/2003US20030148468 Method of preparing antibody by gene immunization
08/07/2003US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases
08/07/2003US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003US20030148456 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/07/2003US20030148454 Producing tumor necrosis factor transmembrane polypeptide; antitumor/anticarcinogenic agents; immunosuppressants
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148444 Sodium-independent small neutral amino acid transporters transporting L- and D-amino acids and genes thereof
08/07/2003US20030148443 Epoxide hydrolases, nucleic acids encoding them and methods of making and using them
08/07/2003US20030148442 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148441 Method for preparing polypeptide variants
08/07/2003US20030148439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148436 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148434 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148432 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148430 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148426 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148425 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148423 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148422 Method for diversifying the chemical composition of proteins produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases
08/07/2003US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003US20030148419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148418 Proteolytic fermenter
08/07/2003US20030148417 Comprises genetically engineered aspartic protease for use in food processing; improving cocoa flavoring; odors
08/07/2003US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors
08/07/2003US20030148408 Compositions and methods for the diagnosis and treatment of tumor
08/07/2003US20030148398 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/07/2003US20030148396 Comprises p65 binding polypeptide (RAI) for diagnosis and treatment of adult respiratory distress syndrome, asthma, allograft rejection, cancer and inflammatory/autoimmune/vasoreconstrictive diseases
08/07/2003US20030148392 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening
08/07/2003US20030148389 Schizophrenia related gene and protein
08/07/2003US20030148388 Patched genes and uses related thereto
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
08/07/2003US20030148378 Phosphodiesterase 10
08/07/2003US20030148376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148373 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148372 Comprises nucleotide sequence repertoire coding antibody polypeptides; anticarcinogenic/antiinflammatory/antiarthritic agents; antiallergens; bactericides; viricides
08/07/2003US20030148371 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148370 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148333 HCV anti-core monoclonal antibodies
08/07/2003US20030148315 Increases complementarity in a heteroduplex polynucleotide sequence
08/07/2003US20030148295 Endothelial cells; nucleotide sequences; microarrays; algorithms
08/07/2003US20030148294 DNA encoding novel chemokine receptors
08/07/2003US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein
08/07/2003US20030148261 Compositions and methods comprising West Nile virus polypeptides
08/07/2003US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof
08/07/2003US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids
08/07/2003US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147894 Useful in the field of remedies for myelocytic leukemia; binds to the myeloid cells
08/07/2003US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
08/07/2003US20030147884 Administering a breast cancer patient (caused by human ErbB2 oncogene which codes a transmebrane glycoprotein receptor related to epidermal growth factor receptor, is overexpressed) an anti ErbB2 antibody and a drug
08/07/2003US20030147880 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
08/07/2003US20030147866 Novel BGP compounds for therapy and diagnosis and methods for using same
08/07/2003US20030147852 Toxin-phage bacteriocide antibiotic and uses thereof
08/07/2003US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells
08/07/2003US20030147831 Hair follicle growth
08/07/2003US20030147809 Antitumor agents
08/07/2003CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003CA2483332A1 Cell extract for cell-free protein synthesis and process for producing the same
08/07/2003CA2480126A1 Cell culture medium for lymphoid cells
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474759A1 Gene for peripheral arterial occlusive disease
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474616A1 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003CA2474466A1 Germ extract for cell-free protein synthesis and process for producing the same
08/07/2003CA2474457A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003CA2474339A1 Multiple virus replicon culture systems
08/07/2003CA2473994A1 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
08/07/2003CA2469571A1 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses
08/06/2003EP1333094A2 Human telomerase catalytic subunit
08/06/2003EP1333093A2 Human muscle nad: arginine adpribosyltransferase
08/06/2003EP1333035A2 Growth differentiation factor-8
1 ... 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 ... 1125